Goldman Sachs’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Sell |
|
|||||
|
2025
Q1 | $42.3M | Sell |
|
|||||
|
2024
Q4 | $38.7M | Sell |
|
|||||
|
2024
Q3 | $42.7M | Buy |
|
|||||
|
2024
Q2 | $5.73M | Buy |
|
|||||
|
2024
Q1 | $4.55M | Buy |
|
|||||
|
2023
Q4 | $2.27M | Buy |
|
|||||
|
2023
Q3 | $2.28M | Sell |
|
|||||
|
2023
Q2 | $3.94M | Buy |
|
|||||
|
2023
Q1 | $2.67M | Sell |
|
|||||
|
2022
Q4 | $2.91M | Sell |
|
|||||
|
2022
Q3 | $2.98M | Sell |
|
|||||
|
2022
Q2 | $4.03M | Buy |
|
|||||
|
2022
Q1 | $439K | Sell |
|
|||||
|
2021
Q4 | $1.76M | Sell |
|
|||||
|
2021
Q3 | $10.2M | Sell |
|
|||||
|
2021
Q2 | $12.7M | Buy |
|
|||||
|
2021
Q1 | $12.2M | Sell |
|
|||||
|
2020
Q4 | $9.95M | Buy |
|
|||||
|
2020
Q3 | $8.81M | Buy |
|
|||||
|
2020
Q2 | $8.86M | Sell |
|
|||||
|
2020
Q1 | $11.5M | Buy |
|
|||||
|
2019
Q4 | $17.2M | Buy |
|
|||||
|
2019
Q3 | $16.4M | Buy |
|
|||||
|
2019
Q2 | $3.8M | Sell |
|
|||||
|
2019
Q1 | $3.9M | Buy |
|
|||||
|
2018
Q4 | $2.33M | Sell |
|
|||||
|
2018
Q3 | $5.93M | Buy |
|
|||||
|
2018
Q2 | $6.29M | Buy |
|
|||||
|
2018
Q1 | $4.79M | Buy |
|
|||||
|
2017
Q4 | $2.27M | Sell |
|
|||||
|
2017
Q3 | $2.28M | Buy |
|
|||||
|
2017
Q2 | $760K | Sell |
|
|||||
|
2017
Q1 | $1.02M | Sell |
|
|||||
|
2016
Q4 | $1.43M | Buy |
|
|||||
|
2016
Q3 | $836K | Buy |
|
|||||
|
2016
Q2 | $535K | Sell |
|
|||||
|
2016
Q1 | $535K | Buy |
|
|||||
|
2015
Q4 | $562K | Buy |
|
|||||
|
2015
Q3 | $380K | Sell |
|
|||||
|
2015
Q2 | $1.8M | Buy |
|
|||||
|
2015
Q1 | $1.13M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.04M | Buy |
|
|||||
|
2014
Q1 | $259K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $33K | Buy |
|